Umizortamig is a monoclonal antibody engineered to target CD3E, EGFR, TNFRSF9, PD-L1, and CD3G. This multi-specific antibody is designed for the simultaneous modulation of key immune checkpoints and signaling pathways, potentially enhancing therapeutic efficacy in oncology and immunotherapy applications. Umizortamig's ability to bind multiple targets allows for a coordinated approach in the regulation of immune responses, making it a valuable tool for research in cancer biology and immune regulation.
Umizortamig is a monoclonal antibody engineered to target CD3E, EGFR, TNFRSF9, PD-L1, and CD3G. This multi-specific antibody is designed for the simultaneous modulation of key immune checkpoints and signaling pathways, potentially enhancing therapeutic efficacy in oncology and immunotherapy applications. Umizortamig's ability to bind multiple targets allows for a coordinated approach in the regulation of immune responses, making it a valuable tool for research in cancer biology and immune regulation.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
